The Food and Drug Administration accepted Apellis Pharmaceuticals' (APLS) application for an eye-disease treatment on Tuesday, leading APLS stock to surge.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,